Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and Cash Equivalents $ 749,090 $ 555,967
Marketable Securities 4,086,902 11,003,071
Prepaid Expenses 565,787 1,106,347
Total Current Assets 5,401,779 12,665,385
Non-Current Assets    
Operating Lease Right-of-Use Assets 139,662 149,009
Goodwill 10,498,539 10,498,539
Investment in Oravax, Inc. 1,500,000 1,500,000
Total Non-Current Assets 12,138,201 12,147,548
Total Assets 17,539,980 24,812,933
Current Liabilities    
Trade and Other Payables 2,673,221 986,626
Due to MyMD Florida Shareholders 29,982
Operating Lease Liability 65,780 53,240
Total Current Liabilities 2,768,983 1,039,866
Non-Current Liabilities    
Due to MyMD Florida Shareholders, net of current portion 29,982
Operating Lease Liability, net of current portion 75,941 95,911
Total Non-Current Liabilities 75,941 125,893
Total Liabilities 2,844,924 1,165,759
Commitments and Contingencies
SHAREHOLDERS’ EQUITY    
Common stock, no par value, 500,000,000 shares authorized 39,470,009 and 37,673,110 issued and outstanding as of December 31, 2022 and December 31, 2021 108,309,436 102,064,218
Accumulated Deficit (93,758,904) (78,561,568)
Total Shareholders’ Equity 14,695,056 23,647,174
Total Liabilities and Shareholders’ Equity 17,539,980 24,812,933
Series D Convertible Preferred Stock [Member]    
SHAREHOLDERS’ EQUITY    
Preferred stock value $ 144,524 $ 144,524